Upon reviewing repeated prostate cancer screenings, researchers observed the absence of suspicious MRI findings in over 86% of men who had prostate-specific antigen (PSA) levels of 3 ng/mL or higher ...

Please provide your email address to receive an email when new articles are posted on . First-line biparametric MRI testing increased the number of biopsies and overdiagnoses vs. first-line PSA ...

Editor's note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine.When I learned that ...

(HealthDay News) — From an economic perspective, first-line prostate-specific antigen (PSA) testing is favored over biparametric magnetic resonance imaging (bpMRI) for prostate cancer screening, ...

We have made important advancements in treatment, but are still being overwhelmed by the number of late-stage cases ...

Prostate cancer is the UK's most common cancer, claiming over 12,000 lives annually due to a lack of early symptoms. Despite rising cases and late diagnoses, the UK National Screening Committee ...

Nearly all men with a polygenic risk score in the 90th percentile or above had a 10-year absolute risk for prostate cancer exceeding 3.8%. A polygenic risk score (PRS) identifies more patients with ...

Mass population testing for prostate cancer will not see men proactively invited for the PSA blood test - here is all you need to know about who can get checked ...

The National Screening Committee (NSC) has told the government that screening is "likely to cause more harm than good".